ClinicalTrials.gov
public full text
Public Domain
Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- NSCLC Relapse Therapy After Surgery and Peri-operative Chemotherapy#905308
- Role of FDG PET, Immune and Hypoxic Marker in NSCLC#1032036
- Phase 2 Trial of Afatinib Plus Prednisone for Advanced Squamous NSCLC#878612
- A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLC#913707
- Anlotinib Combined With Nivolumab for Non-Small Cell Lung Cancer#897717
Record · ID 432899
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive